NICE has recommended cemiplimab for eligible adults with recurrent or [...]

The UK health watchdog NICE has recommended NHS reimbursement of [...]

Context Therapeutics has reported encouraging interim Phase 1 data for [...]

Poolbeg Pharma has activated the first clinical site and begun [...]

CuraCell TX has reported new findings supporting its personalised tumour-infiltrating [...]

People with extensive-stage small cell lung cancer in England and [...]

Mestag Therapeutics has dosed the first patient in its Phase [...]

AstraZeneca’s Imfinzi (durvalumab) has been recommended by NICE for use [...]

Aravax has appointed two senior industry figures to its board [...]

Anixa Biosciences is advancing its breast cancer vaccine programme towards [...]